10: How the MDR has changed the roles and responsibilities of “economic operators”
PharmaLex Talks8 Aug 2022

10: How the MDR has changed the roles and responsibilities of “economic operators”

Under the Medical Devices Regulation economic operators – that is manufacturers, the authorised representative, importers and distributors – all face new roles and obligations. While some of these responsibilities existed under the Medical Devices Directive, workload will be impacted. From requirements around Eudamed, to having a person responsible for regulatory compliance, to ensuring certain obligations are properly followed through to complaint management, the roles of all economic operators are affected and require careful consideration by companies with devices in the European market.

Clare Huntington is Director and Head of Medical Devices / IVD UK at PharmaLex

Clare leads the UK and EU teams and consults on industry-wide issues including drug/device combination products, clinical trials, device classification and regulatory submissions, and post-market requirements. Clare has worked in a variety of roles in the medical device space during her career, including the MHRA, a Clinical Research Organisation, as an EU Authorised Representative, as well as industry, leading the regulatory affairs activities. This has given her a broad understanding of the EU regulatory landscape which enables her to provide comprehensive advice to clients that covers the full product life-cycle.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(37)

29: Exploring the interactions between validation and technology transfer

29: Exploring the interactions between validation and technology transfer

Synopsis: In this podcast, Gerardo Gomez talks about the interactions between validation and technology transfer, considering the views and expectations of the regulators. As Gerardo explains, technol...

24 Jan 202413min

28: Early access programs: What they are and how to plan for them

28: Early access programs: What they are and how to plan for them

Synopsis: Early access programs are designed to allow patients suffering from a life-threatening unmet medical need or disease to be given promising treatments that have not yet received marketing app...

5 Des 202315min

27: Assessing gaps and achieving compliance with Annex 1

27: Assessing gaps and achieving compliance with Annex 1

Bio Patrick Nieuwenhuizen Quality professional with a Microbiology & Sterile Manufacturing background with over 25 years’ experience in the Pharmaceutical Industry. Worked for several global Pharmace...

28 Nov 202315min

26: Navigating the Process of Technology Transfer

26: Navigating the Process of Technology Transfer

Synopsis: Technology transfer involves two main types: scale-up and transfer to a different site. Scale-up technology transfer involves moving a technology or process from a laboratory or pilot-scale ...

14 Nov 202318min

25: Scaling Patient Safety through Innovation

25: Scaling Patient Safety through Innovation

Bio: Michael Braun-Boghos Michael has been working in medicinal product safety for the last three decades. He spent 13 years at the European PV headquarters of Fujisawa, which later became Astellas, ...

25 Sep 202316min

24: Why Early Phase Modeling is Key to Reimbursement and Patient Access

24: Why Early Phase Modeling is Key to Reimbursement and Patient Access

Market access can be a big hurdle for companies to overcome and might require a different approach to the process of gathering evidence to support reimbursement discussions. Early phase modeling can h...

12 Sep 202311min

23: The Unique and Complex World of Combination Products

23: The Unique and Complex World of Combination Products

Combination products offer unique advantages in terms of delivering improved therapeutic outcomes or enhanced patient convenience. Typically, combination products are understood to be a drug-device or...

31 Aug 202310min

22: Avoiding Pitfalls with your Product Development Strategy

22: Avoiding Pitfalls with your Product Development Strategy

Companies often fall into common traps in early-stage product development. These range from interactions with the regulators to their ability to manufacture their product. Forward planning is crucial,...

2 Aug 202312min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
aftenpodden-usa
forklart
popradet
fotballpodden-2
stopp-verden
nokon-ma-ga
rss-espen-lee-usensurert
det-store-bildet
dine-penger-pengeradet
lydartikler-fra-aftenposten
rss-gukild-johaug
hanna-de-heldige
rss-ness
aftenbla-bla
chit-chat-med-helle
rss-dannet-uten-piano
e24-podden
frokostshowet-pa-p5